Page last updated: 2024-10-22

alendronate and Acid beta-Glucosidase Deficiency

alendronate has been researched along with Acid beta-Glucosidase Deficiency in 1 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Research Excerpts

ExcerptRelevanceReference
"Alendronate is a useful adjunctive therapy in combination with enzyme replacement therapy (ERT) for the treatment of GD-related osteopenia in adults, but it cannot be expected to improve focal lesions."6.71Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy. ( Bailey, L; Grabowski, GA; Moskovitz, J; Oestreich, AE; Sun, S; Wenstrup, RJ; Wu, W, 2004)
"Alendronate is a useful adjunctive therapy in combination with enzyme replacement therapy (ERT) for the treatment of GD-related osteopenia in adults, but it cannot be expected to improve focal lesions."2.71Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy. ( Bailey, L; Grabowski, GA; Moskovitz, J; Oestreich, AE; Sun, S; Wenstrup, RJ; Wu, W, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wenstrup, RJ1
Bailey, L1
Grabowski, GA1
Moskovitz, J1
Oestreich, AE1
Wu, W1
Sun, S1

Trials

1 trial available for alendronate and Acid beta-Glucosidase Deficiency

ArticleYear
Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy.
    Blood, 2004, Sep-01, Volume: 104, Issue:5

    Topics: Adult; Alendronate; beta-Glucosidase; Bone Density; Double-Blind Method; Drug Therapy, Combination;

2004